Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.28EUR
−908.04 MEUR
401.12 MEUR
154.79 M
About Ironwood Pharmaceuticals, Inc.
Sector
CEO
Thomas A. McCourt
Headquarters
Boston
Website
Employees (FY)
267
Founded
1998
FIGI
BBG000NF4WN0
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of I76 is 6.00 EUR — it has increased by 2.56% in the past 24 hours. Watch IRONWOOD PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IRONWOOD PHARMACEUTICALS INC stocks are traded under the ticker I76.
I76 stock has risen by 15.38% compared to the previous week, the month change is a 10.09% rise, over the last year IRONWOOD PHARMACEUTICALS INC has showed a 38.14% decrease.
We've gathered analysts' opinions on IRONWOOD PHARMACEUTICALS INC future price: according to them, I76 price has a max estimate of 21.18 EUR and a min estimate of 11.05 EUR. Watch I76 chart and read a more detailed IRONWOOD PHARMACEUTICALS INC stock forecast: see what analysts think of IRONWOOD PHARMACEUTICALS INC and suggest that you do with its stocks.
I76 stock is 3.45% volatile and has beta coefficient of 0.17. Track IRONWOOD PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is IRONWOOD PHARMACEUTICALS INC there?
Today IRONWOOD PHARMACEUTICALS INC has the market capitalization of 920.77 M, it has increased by 10.96% over the last week.
Yes, you can track IRONWOOD PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
IRONWOOD PHARMACEUTICALS INC is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
I76 earnings for the last quarter are −0.03 EUR per share, whereas the estimation was 0.19 EUR resulting in a −114.85% surprise. The estimated earnings for the next quarter are 0.15 EUR per share. See more details about IRONWOOD PHARMACEUTICALS INC earnings.
IRONWOOD PHARMACEUTICALS INC revenue for the last quarter amounts to 69.39 M EUR, despite the estimated figure of 98.01 M EUR. In the next quarter, revenue is expected to reach 100.00 M EUR.
I76 net income for the last quarter is −3.86 M EUR, while the quarter before that showed −984.83 K EUR of net income which accounts for −291.67% change. Track more IRONWOOD PHARMACEUTICALS INC financial stats to get the full picture.
No, I76 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 29, 2024, the company has 267.00 employees. See our rating of the largest employees — is IRONWOOD PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRONWOOD PHARMACEUTICALS INC EBITDA is 117.33 M EUR, and current EBITDA margin is 47.57%. See more stats in IRONWOOD PHARMACEUTICALS INC financial statements.
Like other stocks, I76 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRONWOOD PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRONWOOD PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRONWOOD PHARMACEUTICALS INC stock shows the sell signal. See more of IRONWOOD PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.